Exploring the treatment gap and outcome risks in patients with node-positive, high-risk, HR-positive, HER2-negative early breast cancer: analyses of real-world data
Publication Date
2026
Content Type
article
PubMed ID:
Citation
ESMO Open (2026) 11(2):106021